Viewing Study NCT03692767


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2026-02-13 @ 12:29 PM
Study NCT ID: NCT03692767
Status: UNKNOWN
Last Update Posted: 2019-01-30
First Post: 2018-09-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Anti-CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma
Sponsor: Allife Medical Science and Technology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module